Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications development patient reported assessment identify placebo responders generalized anxiety
… of regulatory protection. However, it incentivizes the development of therapies that address high unmet medical … understand disease burdens, unmet medical needs, and patient preferences. We support clinical trial design by … such as clinical outcomes assessments and patient-reported outcomes measures. Pharma manufacturers in the 2 …
… results (e.g., scientific conferences, peer-reviewed publications ) …
… their oncology product extended time to deterioration in patient-reported health-related quality of life (HRQOL) in 3 … data found no difference between the client’s product and placebo groups. OUR APPROACH As side effects typically occur …
… benign safety profile. We conducted a literature review to identify an appropriate reference antiepileptic drug for …
… With an increased regulatory focus on incorporating patient perspectives in drug development, patient-reported outcomes, known as PROs, are playing an increasingly …
… New FDA Draft Guidance For Evaluating Patient-Reported Outcomes in Clinical Trials Share on: September 3, … The draft offers several recommendations related to the development, evaluation, and regulatory review of clinical …
… Business Development and Marketing …
… of regulatory protection. However, it incentivises the development of therapies that address high unmet medical … understand disease burdens, unmet medical needs, and patient preferences. We support clinical trial design by … such as clinical outcomes assessments and patient-reported outcomes measures. Pharma manufacturers in the two …
Navigating EU Joint Clinical Assessments and Joint Scientific Consultations From January 2025 Onward
… centralise the clinical domains of the health technology assessment (HTA) process on a European level. Non-clinical … HTA Coordination Group. It will include the scope of the assessment, the deadline for submission, the dossier … studies. This includes fundamental criteria, such as patient populations, comparator selection, relevant …
… acceptance Gain reimbursement and Health Technology Assessment (HTA) approvals Differentiate your product FDAMA … methods to uncover hidden subpopulations or differential responders in your data that can lead to new opportunities … efficacy versus effectiveness analyses Health Technology Assessment Strategic consulting, systematic reviews, network …